dextrothyroxine has been researched along with Central Nervous System Cysticercosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
da Silva Santana, RC; de Lima, NF; de Sousa Guerra, CH; de Souza Lino Junior, R; Prudente, TP; Vinaud, MC | 1 |
Hasbun, R; Samannodi, MS; Zhao, A | 1 |
1 review(s) available for dextrothyroxine and Central Nervous System Cysticercosis
Article | Year |
---|---|
Use of Ivermectin in Neurocysticercosis: A Case Report.
Topics: Adult; Anthelmintics; Central Nervous System Helminthiasis; Dose-Response Relationship, Drug; Drug Administration Schedule; Emergency Service, Hospital; Female; Follow-Up Studies; Humans; Ivermectin; Magnetic Resonance Imaging; Neurocysticercosis; Risk Assessment; Seizures; Treatment Outcome; United States | 2018 |
1 other study(ies) available for dextrothyroxine and Central Nervous System Cysticercosis
Article | Year |
---|---|
Albendazole - Ivermectin combination decreases inflammation in experimental neurocysticercosis.
Topics: Albendazole; Animals; Anthelmintics; Anti-Inflammatory Agents; Cysticercus; Inflammation; Ivermectin; Mice; Neurocysticercosis | 2023 |